MDxHealth
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
15279 Alton Pkwy Ste 100, Irvine, Califo...Phone Number
(949) 812-6979Website
www.mdxhealth.comRevenue
$107.9 MillionStock Symbol
MDXHIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
1
2
2
About MDxHealth
MDxHealth operates as a precision diagnostics and molecular testing company focused on improving the detection, diagnosis, and management of urologic diseases, particularly prostate cancer. The organization functions within the biotechnology and molecular diagnostics sector, where scientific research and laboratory technologies are applied to develop tests that help physicians make more informed clinical decisions. By analyzing genetic, genomic, and epigenetic biomarkers present in biological samples, the company provides diagnostic insights that support personalized treatment strategies and earlier identification of disease. The organizations mission centers on advancing precision medicine through innovative molecular diagnostic technologies. Precision medicine refers to a healthcare approach in which medical treatment is tailored to the individual characteristics of each patient, including genetic information and molecular markers associated with disease. MDxHealth develops diagnostiRead more
MDxHealth Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MDxHealth your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MDxHealth recently announced quarterly report
Product Launch: Get notified when MDxHealth launches new products
Congratulate Masked Content for being promoted to Masked Content at MDxHealth
Click to see if MDxHealth had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
MDxHealth, which may be a good buyer, showed buying intent in Masked Content Topic
Check if MDxHealth has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once MDxHealth has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MDxHealth is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
MDxHealth is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MDxHealth is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MDxHealth.
MDxHealth financials insights
Gather financial insights about MDxHealth, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Share Placement
$15.4M
2015
Share Placement
$31M
2016
Share Placement
$22.6M
2018
Share Placement
$44M
2019
Debt
$9.8M
2020
Private Equity
$13.7M
Debt
$2M
2021
Stock Offering
$45M
MDxHealth Tech Stack
A closer look at the technologies used by MDxHealth
See more technologies
Most Recent Scoops
Person-Based
Pain Point
Earnings
MDxHealth has reported an operating loss of $5.1 million for Q2 2026, compared to $1.5 million for Q2 2025, primarily driven by increases in headcount and other operating expenses related to the ExoDx acquisition.
Earnings, Acquisitions, Finance
Earnings
MDxHealth has reported revenue of $27.2 million for Q2 ended June 30, 2026, an increase of 16% compared to Q2 2025. Revenue in Q2 2026 was comprised of 73% from tissue-based tests, compared to 96% for the same period last year.
Earnings, Finance
Earnings
MDxHealth has reported gross profit of $17.9 million for Q2 2026, an increase of 11% compared to $16.1 million for Q2 2025. Gross margins were 65.7% compared to 68.6% for Q2 2025, a decrease of 2.9 percentage points primarily attributed to tissue versus liquid mix.
Earnings, Finance
Person-Based
Earnings, Finance
MDxHealth News & Media
Mdxhealth Reports Second Quarter 2026 Financial Results
Second quarter revenue growth of 16% to $27.2 million Conference call with Q&A today at 4:30 PM EST / 22:30 CETMdxhealth to Release Second Quarter 2026 Financial Results on August 13
Company to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CETMdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities DeficiencyMdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated June 30, 2026, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MDxHealth
Sign Up For FreeTo access detailed company insights
MDxHealth operates as a precision diagnostics and molecular testing company focused on improving the detection, diagnosis, and management of urologic diseases, particularly prostate cancer. The organization functions within the biotechnology and molecular diagnostics sector, where scientific research and laboratory technologies are applied to devel... Read More
